UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
____________________________________________________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
____________________________________________________________
Date of
Report (Date of earliest event reported): December 8, 2010
HealthWarehouse.com,
Inc.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
|
0-13117
|
22-2413505
|
||
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
||
|
of
incorporation)
|
Identification
No.)
|
|||
|
100
Commerce Boulevard
|
||||
|
Cincinnati, Ohio
|
45140
|
|||
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|||
Registrant’s
telephone number, including area code: (513) 618-0911
________________________
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 DFR
240.14a-12)
|
|
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 DFR
240.14a-12)
|
|
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Item
5.02.
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
(a) Not
applicable.
(b) Not
applicable.
(c)
Not
applicable.
(d) On
December 8, 2010, our Board of Directors elected Matthew Stecker as a director
of the Company. Mr. Stecker is currently the CEO and President of
Livewire Mobile, a leading provider of managed personalization services for
mobile operators.
Under the
Certificate of Designation designating the rights and privileges of the
Company’s Series B Preferred Stock, the holders of the Company’s Series B
Preferred Stock have the right to designate or elect one of the Company’s
directors (the “Series B Director”). The holders of a majority of the
Company’s outstanding Series B Preferred shares have designated Mr. Stecker as
the initial Series B Director.
In
connection with Mr. Stecker’s election to the Board, on December 8, 2010, the
Company awarded Mr. Stecker non-qualified stock options to purchase up to 30,000
shares of common stock at an exercise price of $3.75 per share under the
Company’s 2009 Incentive Compensation Plan. Those options have a 10
year term, and vest in equal annual installments on December 8, 2011, December
8, 2012 and December 8, 2013.
(e) Not
applicable.
(f) Not
applicable.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
Date: December
13, 2010
|
HEALTHWAREHOUSE.COM, INC. | |
| By: |
/s/ Lalit Dhadphale
|
|
|
Lalit
Dhadphale
|
||
|
President
and Chief Executive Officer
|
||